View Item 

Show simple item record

Immunoprofiling of oral squamous cell carcinomas reveals high p63 and survivin expression

dc.contributor.authorLauxen, ISen_US
dc.contributor.authorOliveira, MGen_US
dc.contributor.authorRados, PVen_US
dc.contributor.authorLingen, MWen_US
dc.contributor.authorNör, Jeen_US
dc.contributor.authorSant'Ana Filho, Men_US
dc.date.accessioned2014-05-21T18:02:58Z
dc.date.availableWITHHELD_13_MONTHSen_US
dc.date.available2014-05-21T18:02:58Z
dc.date.issued2014-04en_US
dc.identifier.citationLauxen, IS; Oliveira, MG; Rados, PV; Lingen, MW; Nör, Je ; Sant'Ana Filho, M (2014). "Immunoprofiling of oral squamous cell carcinomas reveals high p63 and survivin expression." Oral Diseases 20(3): e76-e80.en_US
dc.identifier.issn1354-523Xen_US
dc.identifier.issn1601-0825en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/106715
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherDiagnostic Markersen_US
dc.subject.otherOral Squamous Cell Carcinomaen_US
dc.subject.otherApoptosisen_US
dc.subject.otherSurvivalen_US
dc.subject.otherCell Cycleen_US
dc.titleImmunoprofiling of oral squamous cell carcinomas reveals high p63 and survivin expressionen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelDentistryen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/106715/1/odi12136.pdf
dc.identifier.doi10.1111/odi.12136en_US
dc.identifier.sourceOral Diseasesen_US
dc.identifier.citedreferenceQi G, Kudo Y, Ando T et al ( 2010 ). Nuclear survivin expression is correlated with malignant behaviours of head and neck cancer together with Aurora‐B. Oral Oncol 46: 263 – 270.en_US
dc.identifier.citedreferenceHibi K, Trink B, Patturajan M et al ( 2000 ). AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 97: 5462 – 5467.en_US
dc.identifier.citedreferenceKatz M, Amit I, Citri A et al ( 2007 ). A reciprocal tensin‐3‐cten switch mediates EGF‐driven mammary cell migration. Nat Cell Biol 9: 961 – 969.en_US
dc.identifier.citedreferenceKeski‐Säntti H, Atula T, Tikka J, Hollmén J, Mäkitie A, Leivo I ( 2007 ). Predictive value of histopathologic parameters in early squamous cell carcinoma of oral tongue. Oral Oncol 43: 1007 – 1013.en_US
dc.identifier.citedreferenceKummoona R, Mohammad Sámi S, Al‐Kapptan I, Al‐Muala H ( 2007 ). Study of antiapoptotic gene of oral carcinoma by using bcl‐2 oncogene. J Oral Pathol Med 37: 345 – 351.en_US
dc.identifier.citedreferenceLaimer K, Spizzo G, Gastl G et al ( 2007 ). High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA‐based immunohistochemical analysis. Oral Oncol 43: 193 – 198.en_US
dc.identifier.citedreferenceLittle N, Jochemsen A ( 2002 ). p63. Int J Biochem Cell Biol 34: 6 – 9.en_US
dc.identifier.citedreferenceMallick S, Patil R, Gyanchandani R et al ( 2009 ). Human oral cancers have altered expression of Bcl‐2 family members and increased expression of the anti‐apoptotic splice variant of Mcl‐1. J Pathol 217: 398 – 407.en_US
dc.identifier.citedreferenceMirzayans R, Andrais B, Scott A, Murray D ( 2012 ). New Insights into p53 Signaling and Cancer Cell Response to DNA Damage: implications for Cancer Therapy. J Biomed Biotechnol 2012: 170325.en_US
dc.identifier.citedreferenceMonteiro LS, Diniz‐Freitas M, Garcia‐Caballero T, Forteza J, Fraga M ( 2010 ). EGFR and Ki‐67 expression in oral squamous cell carcinoma using tissue microarray technology. J Oral Pathol Med 39: 571 – 578.en_US
dc.identifier.citedreferenceNémeth Z, Velich N, Bogdan S, Ujpál M, Szabó G, Suba ZS ( 2005 ). The prognostic role of clinical, morphological and molecular markers in oral squamous cell tumors. Neoplasma 52: 95 – 102.en_US
dc.identifier.citedreferencePatel MP, Masood A, Patel PS, Chanan‐Khan AA ( 2009 ). Targeting the Bcl‐2. Curr Opin Oncol 21: 516 – 523.en_US
dc.identifier.citedreferencePutti TC, To KF, Hsu HC et al ( 2002 ). Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicentre immunohistochemical study in the Asia–Pacific region. Histopathology 41: 144 – 151.en_US
dc.identifier.citedreferenceRosenbluth JM, Johnson K, Tang L, Triplett T, Pietenpol JA ( 2009 ). Evaluation of p63 and p73 antibodies for cross‐reactivity. Cell Cycle 8: 3702 – 3706.en_US
dc.identifier.citedreferenceSlaughter DP, Southwick HW, Smejkal W ( 1953 ). “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 6: 963 – 968.en_US
dc.identifier.citedreferenceTanaka C, Uzawa K, Shibahara T, Yokoe H, Noma H, Tanzawa H ( 2003 ). Expression of an inhibitor of apoptosis, survivin in oral carcinogenesis. J Dent Res 82: 607 – 611.en_US
dc.identifier.citedreferencevan der Vorst S, Dekairelle AF, Weynand B, Hamoir M, Gala JL ( 2012 ). Assessment of p53 functional activity in tumor cells and histologically normal mucosa from patients with head and neck squamous cell carcinoma. Head Neck 34: 1542 – 1550.en_US
dc.identifier.citedreferencevan der Waal I ( 2013 ). Are we able to reduce the mortality and morbidity of oral cancer: some considerations. Med Oral Patol Oral Cir Bucal 18: e33 – e37.en_US
dc.identifier.citedreferenceWarfel NA, El‐Deiry WS ( 2013 ). p21 WAF1 and tumourigenesis: 20 years after. Curr Opin Oncol 25: 52 – 58.en_US
dc.identifier.citedreferenceWeinberg WC, Denning MF ( 2002 ). p21 WAF1 control of epithelial cell cycle and cell fate. Crit Rev Oral Biol Med 13: 453 – 464.en_US
dc.identifier.citedreferenceWhyte DA, Broton CE, Shillitoe EJ ( 2002 ). The unexplained survival of cells in oral cancer: what is the role of p53? J Oral Pathol Med 31: 125 – 133.en_US
dc.identifier.citedreferenceYang A, Kaghad M, Wang Y et al ( 1999 ). p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398: 714 – 718.en_US
dc.identifier.citedreferenceYang A, Kaghad M, Caput D, McKeon F ( 2002 ). On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 18: 90 – 95.en_US
dc.identifier.citedreferenceBascones C, Gonzalez‐Moles MA, Esparza G et al ( 2005 ). Apoptosis and cell cycle arrest in oral lichen planus: hypothesis on their possible influence on its malignant transformation. Arch Oral Biol 50: 873 – 881.en_US
dc.identifier.citedreferenceBidaud P, Chasle J, Sichel F et al ( 2010 ). Expression of p53 family members and CD44 in oral squamous cell carcinoma (OSCC) in relation to tumorigenesis. Histol Histopathol 25: 331 – 339.en_US
dc.identifier.citedreferenceBurz C, Berindan‐Neagoe I, Balacescu O, Irimie A ( 2009 ). Apoptosis in cancer: key molecular signaling pathways and therapy targets. Acta Oncol 48: 811 – 821.en_US
dc.identifier.citedreferenceCandi E, Rufini A, Terrinoni A et al ( 2006 ). Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ 13: 1037 – 1047.en_US
dc.identifier.citedreferenceCandi E, Cipollone R, di Val Cervo PR, Gonfloni S, Melino G, Knight R ( 2008 ). p63 in epithelial development. Cell Mol Life Sci 65: 3126 – 3133.en_US
dc.identifier.citedreferenceChoi H, Tucker SA, Huang Z et al ( 2003 ). Differential expressions of cyclin‐dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki‐67 in oral squamous tumorigenesis. Int J Oncol 22: 409 – 414.en_US
dc.identifier.citedreferenceDe Maria S, Pannone G, Bufo P et al ( 2009 ). Survivin gene‐expression and splicing isoforms in oral squamous cell carcinoma. J Cancer Res Clin Oncol 135: 107 – 116.en_US
dc.identifier.citedreferenceGomes CC, Drummond SN, Guimarães AL, Andrade CI, Mesquita RA, Gomez RS ( 2008 ). P21⁄WAF1 and cyclin D1 variants and oral squamous cell carcinoma. J Oral Pathol Med 37: 151 – 156.en_US
dc.identifier.citedreferenceGrizzi F, Di Ieva A, Russo C et al ( 2006 ). Cancer initiation and progression: an unsimplifiable complexity. Theor Biol Med Model 17: 3 – 37.en_US
dc.identifier.citedreferenceGurgel CA, Ramos EA, Azevedo RA et al ( 2008 ). Expression of Ki‐67, p53 and p63 proteins in keratocyst odontogenic tumours: an immunohistochemical study. J Mol Histol 39: 311 – 316.en_US
dc.identifier.citedreferenceHerbst RS ( 2004 ). Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 59: 21 – 26.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
odi12136.pdf
Size:
325.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.